A series of studies have shown that CXCL9, IL15 and CCL5 up-regulated significantly in hepatocytes of HCV-infected patients and MASH patients, and existed a correlation between CXCL9 levels and liver fibrosis (32–35). The gene discussed is CXCL9; the disease is metabolic dysfunction-associated steatohepatitis.